Qingsong Health (02661) has announced that its board of directors passed a resolution to exercise the share repurchase authorization on June 22, 2026.

Under this authorization, the company may repurchase its issued shares on the open market with a maximum value of HK$100 million, effective from the date of this announcement until the conclusion of the forthcoming annual general meeting of shareholders.

The company anticipates that the repurchases under this share buyback authorization will be funded using surplus cash from its balance sheet.